Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantation

Trial Profile

Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantation

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 05 Sep 2014

At a glance

  • Drugs Liver cell therapy (Primary)
  • Indications Hepatic encephalopathy; Liver failure
  • Focus Therapeutic Use
  • Sponsors Cytonet
  • Most Recent Events

    • 05 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top